Outset provided 2025 revenue guidance of $115M to $125M , and non-GAAP gross margin guidance in the high-30% range. Additionally, the company expects to use less than $50 million of cash in 2025 as compared to the $103 million used in 2024
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OM:
- OM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Outset Medical announces resolution of FDA warning letter
- Outset Medical files $100M mixed securities shelf
- Strategic Inventory Management and Operational Resilience Justify Buy Rating for Outset Medical
- Outset Medical price target lowered to $3 from $4 at BTIG
Questions or Comments about the article? Write to editor@tipranks.com